Jonathan Arnold, MD
Undersea and Hyperbaric Medicine · Cedar Rapids, IANPI 1497747935
Payments from drug & device makers
Across 82 payments — averaging $313.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$24K
- ETS Wound Care LLC$580
- AbbVie$249
- Medline Industries LP$238
- Integra Lifesciences Corporation$118
- Urgo Medical North America, LLC$113
- plus $312 from 8 others
What the payments were for
- Consulting fees$1,4386%
- Speaking & faculty fees$16,06762%
- Travel & lodging$6,44525%
- Food & beverage$1,7757%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 37 | $24,133 |
| ETS Wound Care LLC | 3 | $580 |
| AbbVie(2 entities) | 15 | $249 |
| Medline Industries LP | 5 | $238 |
| Integra Lifesciences Corporation | 1 | $118 |
| Urgo Medical North America, LLC | 3 | $113 |
| Smith+Nephew | 6 | $106 |
| Organogenesis Inc. | 5 | $86 |
| Melinta Therapeutics, LLC | 2 | $33 |
| Kerecis Limited | 1 | $29 |
| Convatec Inc. | 1 | $17 |
| Next Science LLC | 1 | $16 |
| Solventum Corporation | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SNAP$22,283
- PREVENA$2,178
- VAC VERAFLO$1,500
- KERRACONTACT AG (US)$1,500
- ACTIV.A.C.$938
- DERMATAC$450
- ABTHERA$445
- INTEGRA$353
- 3M Cavilon$188
- ABTHERA ADVANCE$188
- PROMOGRAN PRISMA$188
- V.A.C. ATS$150
- ACTIVAC$122
- INTEGRA DERMAL REGENERATION TEMPLATE$118
- PRIMATRIX$118
How this compares
Too few undersea and hyperbaric medicine providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 50 | $1,692 |
| Clotrimazole | 35 | $1,142 |
| Triamcinolone Acetonide | 83 | $917 |
| Silver Sulfadiazine | 47 | $741 |
| Doxycycline Hyclate | 59 | $449 |
| Nystatin | 17 | $367 |
| SsdSilver Sulfadiazine | 26 | $353 |
| Mupirocin | 62 | $337 |
| Hydrocortisone | 15 | $287 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $112 |
| Metronidazole | 13 | $102 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Cedar Rapids
- Mark GomezIowa City$83
- Daniel SchroederDes Moines$12
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.